Refractory Acute Myeloid Leukemia
Showing NaN - NaN of 6
The Pediatric Acute Leukemia Screening Trial - A Study to Test
Recruiting
- Recurrent Acute Lymphoblastic Leukemia
- +7 more
- Biospecimen Collection
-
Birmingham, Alabama
- +144 more
Jan 30, 2023
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute
Active, not recruiting
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
- +2 more
-
Columbus, Ohio
- +2 more
Aug 10, 2022
Allogeneic Stem Cell Transplant Recipient, Blasts 10 Percent or More of Bone Marrow Nucleated Cells, Recurrent Acute Myeloid
Recruiting
- Allogeneic Stem Cell Transplant Recipient
- +3 more
- Cytarabine Hydrochloride
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Feb 7, 2022
Blasts More Than 5 Percent of Bone Marrow Nucleated Cells, Persistent Disease, Refractory Acute Myeloid Leukemia Trial in
Unknown status
- Blasts More Than 5 Percent of Bone Marrow Nucleated Cells
- +2 more
- Liposome-encapsulated Daunorubicin-Cytarabine
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Aug 6, 2019
Recurrent Adult Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Columbus (Azacitidine, Cytarabine, Etoposide
Completed
- Recurrent Adult Acute Myeloid Leukemia
- Refractory Acute Myeloid Leukemia
- Azacitidine
- +5 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Sep 20, 2017
Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in
Completed
- Previously Treated Myelodysplastic Syndrome
- +5 more
- Cytarabine
- +4 more
-
Columbus, Ohio
- +1 more
Aug 1, 2017